| (altrenogest)
MATRIX is the only product that lets you
synchronize estrus in your gilt pool for maximum operational
efficiency. They come into heat during the same period,
are bred at the same time, and farrow on the same schedule.
Their pigs are weaned together, finish together and are delivered
to the packer together.
You'll have better
flow management with less variation, and your packer will
receive a more consistent product.
Benefits of MATRIX
- MATRIX
gives swine producers unparalleled control of estrus
synchronization in sexually mature, cycling females.
This leads to maximal operating efficiency and profitability.
- MATRIX offers a convenient handling system
to minimize handling concerns and simple storage requirements
to maintain maximum product quality.
- Reduce costs and increase profitability.
MATRIX can potentially lower your labor costs by dramatically
reducing heat checking and virtually eliminating weekend
breeding and farrowing(1).
Additionally, with MATRIX, up to 85% of your treated gilts
will be in estrus within 4-9 days after MATRIX withdrawal,
which can impact your bottom line in a number
of ways.
MATRIX works like nothing else.
MATRIX (altrenogest) is a synthetic progestagen,
the only product of its kind on the market for the suppression
and synchronization of estrus.
Progesterone is a naturally occurring steroid
hormone in the swine estrous
cycle with the primary function of maintaining pregnancy.
MATRIX can reduce normal biological variations in reproduction
and improve production efficiency.
Apply 6.8 mL of MATRIX directly to each
gilts feed once every day, for 14 consecutive days.
Gilts should come into estrus 4-9 days after the removal of
MATRIX from their diet. See how
it works.
Always
read the Product
Label for important
safety information before using MATRIX.
References
1.
Flowers, William L. "Dose confirmation study in sexually mature
gilts orally administered altrenogest (Regu-Mate solution
0.22%) to suppress and synchronize estrus." Summary and statistical
analyses report. Sponsor study number: HRV 97-0014. June 29,
1999. Intervet Inc., Millsboro, Del.
|